Events

Recall of Alere Afinion ACR Control. An in vitro diagnostic medical device (IVD)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Inverness Medical Innovations Australia Pty Ltd T/A Alere.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2018-RN-00355-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2018-04-23
  • Event Country
    Australia
  • Event Source
    DHTGA
  • Event Source URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2018-RN-00355-1
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Alere has identified that the target values and acceptable ranges of albumin stated in the package insert of certain control lots is incorrect. the affected alere afinion acr control lots may give albumin results outside the acceptable range stated in the package insert. the creatinine target values and acceptable ranges are not affected. the alere afinion acr test kit is not affected.
  • Action
    Alere is advising customers to inspect stock for lots 10193874 and 10195060, discontinue use of, and discard all kits from the impacted lots. Alere will be providing replacement product to users.

Device

Alere Afinion ACR Control. An in vitro diagnostic medical device (IVD)
  • Model / Serial
    Alere Afinion ACR Control. An in vitro diagnostic medical device (IVD)Catalogue Number: Af1116046Lot Numbers: 10193874, 10195060ARTG: 204476(Inverness Medical Innovations Australia T/A Alere - Clinical chemistry substrate IVDs)
  • Manufacturer
    Inverness Medical Innovations Australia Pty Ltd T/A Alere

Manufacturer

Inverness Medical Innovations Australia Pty Ltd T/A Alere
  • Manufacturer Parent Company (2017)
    Abbott Laboratories
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    DHTGA